Learn / MANE
NYSE: MANE
Veradermics (MANE) stock, explained like you're 5
Veradermics trades on the New York Stock Exchange under the ticker MANE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.5 billion dollars.
- Ticker
- MANE
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 5.5 billion dollars
Is Veradermics a small, medium or large cap company?
No. Veradermics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Veradermics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MANE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Top Veradermics (MANE) Competitors 2026 (MarketBeat)
- Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally (Yahoo Finance)
- Forget GLP 1 stocks, baldness drugs are Wall Street’s next goldmine (Fortune)
- Insider Sale: Director at $MANE Sells 690,601 Shares (Moomoo)
- Veradermics, Incorporated (NYSE:MANE) Stock Has Consensus Price Target of $153.00 According to Brokerages (MarketBeat)
Follow MANE in your daily brief
Each trading day at 5 PM ET we post what happened to Veradermics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MANE
Questions about Veradermics stock
What does Veradermics do?
Veradermics trades on the New York Stock Exchange under the ticker MANE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.5 billion dollars.
What is the ticker symbol for Veradermics?
Veradermics trades under the ticker MANE on the New York Stock Exchange.
What is Veradermics's market cap?
Veradermics is a mid cap stock with a market cap of about 5.5 billion dollars.
How does Veradermics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MANE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MANE stock every day?
Add MANE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.